FilingReader Intelligence
Natco Pharma receives FDA clearance for manufacturing plant
July 24, 2025 at 07:13 PM UTC•By FilingReader AI
Natco Pharma Limited received an Establishment Inspection Report from the U.S. FDA for its Mekaguda API manufacturing plant following a June inspection, with only one minor observation noted.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:NATCOPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Natco Pharma publishes news
Free account required • Unsubscribe anytime